Total Payments
$148,501
2024 Payments
$12,380
Companies
10
Transactions
151
Medicare Patients
6,048
Medicare Billing
$270,105
Payment Breakdown by Category
Other$139,213 (93.7%)
Travel$6,239 (4.2%)
Food & Beverage$2,119 (1.4%)
Consulting$930.00 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $139,213 | 69 | 93.7% |
| Travel and Lodging | $6,239 | 35 | 4.2% |
| Food and Beverage | $2,119 | 46 | 1.4% |
| Consulting Fee | $930.00 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $105,905 | 88 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $26,813 | 41 | $0 (2024) |
| Lilly USA, LLC | $14,590 | 14 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $930.00 | 1 | $0 (2019) |
| Abbott Laboratories | $146.43 | 2 | $0 (2019) |
| Impulse Dynamics (USA) Inc. | $65.89 | 1 | $0 (2024) |
| BOSTON SCIENTIFIC CORPORATION | $17.93 | 1 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $10.67 | 1 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $10.65 | 1 | $0 (2017) |
| Actelion Pharmaceuticals US, Inc. | $10.37 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,380 | 18 | Lilly USA, LLC ($7,371) |
| 2023 | $4,247 | 5 | Boehringer Ingelheim Pharmaceuticals, Inc. ($3,147) |
| 2022 | $10,052 | 13 | Boehringer Ingelheim Pharmaceuticals, Inc. ($8,292) |
| 2021 | $9,039 | 10 | Boehringer Ingelheim Pharmaceuticals, Inc. ($7,914) |
| 2020 | $8,402 | 11 | Lilly USA, LLC ($3,235) |
| 2019 | $15,275 | 11 | Novartis Pharmaceuticals Corporation ($14,225) |
| 2018 | $24,884 | 23 | Novartis Pharmaceuticals Corporation ($24,840) |
| 2017 | $64,221 | 60 | Novartis Pharmaceuticals Corporation ($64,190) |
All Payment Transactions
151 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Impulse Dynamics (USA) Inc. | Optimizer (Device), Optimizer | Food and Beverage | Cash or cash equivalent | $65.89 | General |
| Category: Cardiovascular Device | ||||||
| 12/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,750.00 | General |
| Category: DIABETES | ||||||
| 08/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,425.00 | General |
| Category: DIABETES | ||||||
| 07/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $45.09 | General |
| Category: DIABETES | ||||||
| 06/27/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $880.00 | General |
| Category: Diabetes | ||||||
| 06/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $880.00 | General |
| Category: Diabetes | ||||||
| 06/06/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $880.00 | General |
| Category: Diabetes | ||||||
| 03/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $336.59 | General |
| Category: DIABETES | ||||||
| 03/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $185.00 | General |
| Category: DIABETES | ||||||
| 03/05/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Travel and Lodging | Cash or cash equivalent | $90.00 | General |
| Category: Diabetes | ||||||
| 03/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: DIABETES | ||||||
| 03/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: DIABETES | ||||||
| 03/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $40.00 | General |
| Category: DIABETES | ||||||
| 03/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $40.00 | General |
| Category: DIABETES | ||||||
| 03/05/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Travel and Lodging | Cash or cash equivalent | $20.97 | General |
| Category: Diabetes | ||||||
| 02/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $880.00 | General |
| Category: Diabetes | ||||||
| 01/31/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,740.00 | General |
| Category: Diabetes | ||||||
| 01/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $21.35 | General |
| Category: DIABETES | ||||||
| 12/04/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Travel and Lodging | In-kind items and services | $516.68 | General |
| Category: DIABETES | ||||||
| 10/27/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $220.00 | General |
| Category: Diabetes | ||||||
| 09/26/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,750.00 | General |
| Category: DIABETES | ||||||
| 06/14/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $880.00 | General |
| Category: Diabetes | ||||||
| 03/21/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $880.00 | General |
| Category: DIABETES | ||||||
| 10/19/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $880.00 | General |
| Category: DIABETES | ||||||
| 10/13/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $880.00 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 2,014 | 2,364 | $405,293 | $87,354 |
| 2022 | 24 | 1,536 | 1,712 | $297,058 | $65,186 |
| 2021 | 23 | 1,382 | 1,555 | $274,310 | $66,724 |
| 2020 | 22 | 1,116 | 1,246 | $202,292 | $50,840 |
Total Patients
6,048
Total Services
6,877
Medicare Billing
$270,105
Procedure Codes
97
All Medicare Procedures & Services
97 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 202 | 236 | $109,296 | $21,496 | 19.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 293 | 297 | $74,905 | $15,306 | 20.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 146 | 146 | $35,748 | $8,529 | 23.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 63 | 113 | $28,225 | $6,520 | 23.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 50 | 50 | $23,350 | $4,942 | 21.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 30 | 34 | $22,014 | $4,618 | 21.0% |
| 93264 | Remote monitoring of pulmonary artery pressure sensor, up to 30 days | Office | 2023 | 15 | 110 | $19,837 | $4,213 | 21.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $16,156 | $3,286 | 20.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 15 | 22 | $7,797 | $1,891 | 24.3% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 167 | 167 | $8,655 | $1,800 | 20.8% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 142 | 209 | $5,278 | $1,724 | 32.7% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 106 | 107 | $8,365 | $1,686 | 20.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 12 | $8,305 | $1,596 | 19.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 101 | 107 | $4,411 | $1,404 | 31.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 111 | 146 | $1,858 | $1,226 | 66.0% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 14 | 14 | $5,478 | $1,157 | 21.1% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 53 | 56 | $5,046 | $1,082 | 21.4% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Facility | 2023 | 20 | 20 | $5,060 | $1,073 | 21.2% |
| 83880 | Natriuretic peptide (heart and blood vessel protein) level | Office | 2023 | 17 | 22 | $2,261 | $846.34 | 37.4% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2023 | 44 | 45 | $3,810 | $646.88 | 17.0% |
| 84460 | Liver enzyme (sgpt), level | Office | 2023 | 97 | 104 | $1,686 | $534.57 | 31.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 39 | 41 | $2,217 | $427.62 | 19.3% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 72 | 75 | $1,964 | $412.09 | 21.0% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 86 | 90 | $1,055 | $218.10 | 20.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 11 | 13 | $627.00 | $213.98 | 34.1% |
About Dr. Eric Ernst, M.D
Dr. Eric Ernst, M.D is a Cardiovascular Disease healthcare provider based in Edina, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1437136819.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Ernst, M.D has received a total of $148,501 in payments from pharmaceutical and medical device companies, with $12,380 received in 2024. These payments were reported across 151 transactions from 10 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($139,213).
As a Medicare-enrolled provider, Ernst has provided services to 6,048 Medicare beneficiaries, totaling 6,877 services with total Medicare billing of $270,105. Data is available for 4 years (2020–2023), covering 97 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Edina, MN
- Active Since 12/28/2005
- Last Updated 05/29/2012
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1437136819
Products in Payments
- ENTRESTO (Drug) $105,905
- JARDIANCE (Drug) $41,404
- FARXIGA (Drug) $930.00
- Mitra Clip system (Device) $120.03
- Optimizer (Device) $65.89
- CardioMEMS HF System (Device) $26.40
- VIGILANT (Device) $17.93
- PRALUENT ALIROCUMAB INJECTION (Biological) $10.67
- XARELTO (Drug) $10.65
- OPSUMIT MACITENTAN (Drug) $10.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Edina
Christopher Foley, Md, MD
Cardiovascular Disease — Payments: $225,434
Cardiovascular Disease $225,434
Timinder Biring, Md, MD
Cardiovascular Disease — Payments: $38,477
Cardiovascular Disease $38,477
Dr. Dominic Plucinski, Md, MD
Cardiovascular Disease — Payments: $36,039
Cardiovascular Disease $36,039
Steven Heifetz, M.d, M.D
Cardiovascular Disease — Payments: $18,854
Cardiovascular Disease $18,854
Demosthenes Iskos, Md, MD
Cardiovascular Disease — Payments: $10,249
Cardiovascular Disease $10,249
Joseph Knapper, M.d, M.D
Cardiovascular Disease — Payments: $4,045
Cardiovascular Disease $4,045